Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
Neomics has found a very promising target, AIMP2/AIMP2-DX2 for siRNA therapy application to tumoric lung cancer cells and we intend to focus the remaining resources on developing through clinical trials, the siRNA therapy as a first priority More
Recently characterized MUC17 gene highly specific for pancreatic cancer. More
Acetaminophen-protein Adduct Dipstick: rapid, sensitive and specific diagnostic device for point-of-care determination of acetaminophen toxicity More
Monoclonal antibody for a novel HIV protein with potential diagnostic, prognostic, and therapeutic uses. More
Diagnostic and potential therapeutic applications for mucin gene 4 (MUC4). More
Prognostic Test / Diagnostic Screening Multiple Myeloma and other cancers More
Cripto-1 is overexpressed in infarcted myocardial tissue More
Novel diagnostic and prognostic gene array classification system More
Adrenomedullin peptides and antibodies, which would be useful in the development of a therapeutic or for diagnostics use More
Related Reports
Market Research Reports provided by reports.iptechex.com
May 2011 - 102 pages - $3,835
Apr 2011 - 951 pages - $4,995
Aug 2008 - 352 pages - $2,615
Nov 2011 - 50 pages - $3,800
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
Apr 2008 - 265 pages - $3,835
Jan 2007 - 90 pages - $1,995
Aug 2010 - 27 pages - $125
Sep 2010 - 25 pages - $99
Jun 2011 - 187 pages - $3,835
Feb 2012 - 1350 pages - $2,695
Your selection
Browse By
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us